Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>UBS Cuts PA GOODDOCTOR's TP to HKD16.5, Rating Neutral
Recommend 11 Positive 4 Negative 12 |
||||
|
||||
|
UBS published a research report saying that PA GOODDOCTOR (01833.HK) had completed its strategic 2.0 transformation, with which its 2024-27 revenue CAGR is estimated to reach 12.7%, with room for improvement in profit margins. The broker has resumed coverage on PA GOODDOCTOR with a Neutral rating and a target price cut from HKD20 to HKD16.5. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
